Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating acute cholecystitis and preparing method thereof

A technology for acute cholecystitis and a composition, applied in the field of medicine, can solve problems such as poor treatment effect, destruction of intestinal flora, and impact on the physical and mental health of patients

Inactive Publication Date: 2016-02-17
QINGDAO MERRITT MEDICAL TECH CO LTD
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there are many western medicines for the treatment of acute cholecystitis, but most of them have poor curative effects, and also have disadvantages such as high treatment cost and large side effects, which may even affect the health of patients in severe cases.
Antibiotics have a good therapeutic effect on acute cholecystitis, but long-term use of antibiotics can lead to antibiotic resistance in the human body, and its use will destroy the balance of intestinal flora, causing serious impact on the physical and mental health of patients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for treating acute cholecystitis and preparing method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] Embodiment 1 tablet / capsule

[0021] The parts by weight of each Chinese medicine in the prescription are:

[0022] 20 parts of Bupleurum chinensis, 20 parts of Citrus aurantium, 15 parts of Luo Xingcao, 10 parts of coltsfoot, 15 parts of trigonum, 9 parts of horseshoe gold, 15 parts of Cyperus cyperi, 9 parts of green bark, and 15 parts of green calyx plum.

[0023] Preparation process: Take the prescription amount of each Chinese medicinal material and crush it into fine powder, extract it twice with warm water for 2 hours each time, combine the extracts, filter, concentrate the filtrate to a thick paste with a relative density of 1.03-1.40, and let it cool , add ethanol to make the alcohol content 40%-80%, let it stand, filter the supernatant, recover the ethanol, concentrate to a relative density of 1.1-1.40 extract, dry and pulverize to make a dry paste powder, and then add conventional auxiliary materials Utilize existing technology to prepare into tablet or caps...

Embodiment 2

[0024] Embodiment 2 tablet / capsule

[0025] The parts by weight of each Chinese medicine in the prescription are:

[0026] 10 parts of Southern Bupleurum, 5 parts of Citrus aurantii, 5 parts of Luo Xingcao, 5 parts of Coltsfoot, 5 parts of Trigonum, 3 parts of Rhizoma Rhizoma, 5.5 parts of Cyperus Cyperi, 6 parts of Qingpi, 10 parts of Green Calyx Plum.

[0027] The preparation method is the same as in Example 1.

Embodiment 3

[0028] Embodiment 3 tablet / capsule

[0029] The parts by weight of each Chinese medicine in the prescription are:

[0030] 15 parts of Bupleurum chinensis, 15 parts of Citrus aurantium, 10 parts of Luo Xingcao, 8 parts of coltsfoot, 10 parts of trigonum, 6 parts of horseshoe gold, 10 parts of Cyperus cyperi, 8 parts of green bark, and 12 parts of green calyx plum.

[0031] The preparation method is the same as in Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of traditional Chinese medicine and relates to a pharmaceutical composition and a preparing method thereof, in particular to a pharmaceutical composition for treating acute cholecystitis and a preparing method thereof. Aiming at the defects of being high in hepatotoxicity and poor in curative effect of existing chemotherapic drugs for treating acute cholecystitis, the pharmaceutical composition for treating or preventing acute cholecystitis is prepared from B.scorzonerifolium willd, fructus aurantii, canscora melastomacea, flos farfarae, trigone, creeping dichondra, rhizoma cyperi, pericarpium citri reticulatae viride and armeniaca mume. The pharmaceutical composition has good effects in both treating and preventing acute cholecystitis, the side effect is small, and the clinical promotional value is high.

Description

technical field [0001] The invention belongs to the field of medicine, and in particular relates to a pharmaceutical composition for treating acute cholecystitis and a preparation method thereof. Background technique [0002] Acute cholecystitis is gallbladder inflammation caused by cystic duct obstruction and bacterial invasion. The main symptoms are right upper quadrant pain, nausea, vomiting and fever. At present, there are many Western medicines for the treatment of acute cholecystitis, but most of them have poor curative effect, and also have disadvantages such as high treatment cost and large side effects, which even affect the health of patients in severe cases. Antibiotics have a good therapeutic effect on acute cholecystitis, but long-term use of antibiotics can lead to antibiotic resistance in the human body, and its use will destroy the balance of intestinal flora, causing serious impact on the physical and mental health of patients. [0003] Acute cholecystitis ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/902A61P1/16
CPCA61K36/233A61K36/28A61K36/39A61K36/48A61K36/51A61K36/736A61K36/752A61K36/8905A61K36/902A61K2236/331A61K2236/39A61K2236/51A61K2236/53A61K2300/00
Inventor 吴兴连
Owner QINGDAO MERRITT MEDICAL TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products